This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 44/2/217    most recent 01.HYP.0000135868.38343.c6v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xu, J.-W. Articles by Yamori, Y. Search for Related Content PubMed PubMed Citation Articles by Xu, J.-W. Articles by Yamori, Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Nutrition Endothelium/vascular type/nitric oxide

(Hypertension. 2004;44:217.)
© 2004 American Heart Association, Inc.

Scientific Contributions

Upregulation of Endothelial Nitric Oxide Synthase by Cyanidin-3-Glucoside, a Typical Anthocyanin Pigment

From the Frontier Health Science (J.-W.X., K.I.), School of Human Environmental Science and Research Center for Life-Style Related Diseases (J.-W.X., K.I.), MUKOGAWA Women’s University, Nishinomiya; WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases (Y.Y.), Kyoto, Japan.

Correspondence to Jin-Wen Xu, MD, PhD, Frontier Health Science, School of Human Environmental Science, MUKOGAWA Women’s University, Nishinomiya, Hyogo, 663-8179, Japan. E-mail jwxu{at}mwu.mukogawa-u.ac.jp

Endothelial nitric oxide synthase (eNOS) plays an important role in maintaining blood pressure homeostasis and vascular integrity. Natural dietary flavoniods are thought to protect against cardiovascular diseases by acting as antioxidants and vasodilatants. This study examined the effect of cyanidin-3-glucoside (Cy3G), a typical anthocyanin pigment, on eNOS expression. Treatment of bovine artery endothelial cells (BAECs) with Cy3G for 8 hours of enhanced eNOS protein expression in a dose- and time-dependent manner was determined by Western blot analysis. Longer incubation (12, 16, and 24 hours) of BAECs with 0.1 µmol/L of Cy3G caused a further increase in eNOS expression, and subsequently Cy3G also significantly increased nitric oxide output 2-fold (24 hours). Furthermore, Cy3G stimulated the phosphorylation of Src and extracellular signal-regulated kinase 1/2 (ERK1/2) in a time-dependent manner. An Src kinase inhibitor, pp2, and MEK inhibitor, PD98059, blocked the ERK1/2 phosphorylation and eNOS expression. Transfection with dominant-negative Src cDNA also inhibited the eNOS expression stimulated by Cy3G. In addition, stimulation with Cy3G for 30 minutes resulted in a phosphorylation of Sp1 that was blocked by PD98059. Cy3G enhanced the binding activity of the transcription factor Sp1 to the GC box in the proximal eNOS promoter of BAECs, as revealed by chromatin immunoprecipitation assay. The present study demonstrated that Cy3G induced eNOS expression and escalated NO production via an Src-ERK1/2-Sp1 signaling pathway in vascular endothelial cells. Increased eNOS expression may help to ameliorate endothelial dysfunction, harmonize blood pressure, and prevent atherosclerosis as long-term beneficial effects of flavoniods.

Key Words: nutrition • nitric oxide synthase • endothelium • signal transduction • gene expression

This article has been cited by other articles:

				G. E. Mann, D. J. Rowlands, F. Y.L. Li, P. de Winter, and R. C.M. Siow Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression Cardiovasc Res, July 15, 2007; 75(2): 261 - 274. [Abstract] [Full Text] [PDF]

				D. R. Bell and K. Gochenaur Direct vasoactive and vasoprotective properties of anthocyanin-rich extracts J Appl Physiol, April 1, 2006; 100(4): 1164 - 1170. [Abstract] [Full Text] [PDF]

				D. Grassi, S. Necozione, C. Lippi, G. Croce, L. Valeri, P. Pasqualetti, G. Desideri, J. B. Blumberg, and C. Ferri Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives Hypertension, August 1, 2005; 46(2): 398 - 405. [Abstract] [Full Text] [PDF]